Cytogenix (fka CYGX)

[bigworld]

This is the stock I have been waiting my whole investing life for. A stock with unlimited upward potential, but with a minimal downside. I have been accumulating since August, 10 K here, 10 K there. Most buys were between 23 cents and 27 cents.
Most in Roth IRA's. I had hoped we would stay in the 20's until after the first week of January when we could add $8000 more to our Roths and pick up 20 K more shares. What is our potential? In my view this has the potential to be the next Amgen. If you had invested $10 K in Amgen in 1987 you'd have something like 1.4 million today after all the stock splits. The sepsis drug's potential: There is really no competition right now. Patients go septic, you pump 3 or 4 antibiotics into them. Some get better, most do not. The only drug on the market, Xigris, has limited use. In our hospital it's use is very restricted, and even then it seldom works and is very espensive. Bacteria are getting immune to Vancomycin; Zyvox will suffer the same fate, as will Cubicin. If it works half as well in humans as in lab rats we are talking about a multi billion dollar drug. Throw in drugs for methicillin resistant staph aureus (MRSA), Vancomycin resistant Enterococcus (VRE), resistant TB, and Clostridium Difficille (all possible with this technology), and you have one company solving the most vexing problems in infectious disease. What is that worth?
The herpes cream could garner a nice market worldwide. If the cream could keep people from having to take Valtrex (very expensive) constantly, it would earn some very nice profits. It would seem easier to get a study and an approval for the Herpes product, and use those profits to fund the other drugs.
The psoriasis cream is an afterthought with the potential of the other compounds. And the latest news about purified DNA is only icing on the cake. And it came out of left field. Another potential significant revenue stream. I have read everyone's posts for some time now. Management bashing..probably some of it deserved. But they haven't been able to attract scientific talent and keep the entity running over the past several years without some talent and extremely hard work. But they will be rewarded, we will be rewarded, and the day will come when we sing their praises...and that day is not that far off. Congrats to the loyal longs. Investing in this company has taken research, vision and faith. To all the other posters...Happy Holidays to all.